{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:19:09Z","timestamp":1787663949518,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Early surgical treatment is important to allow a prompt start for rehabilitation after hip fracture. In patients using antithrombotic drugs, the surgery is often delayed, but it is unclear how this affects early post-operative recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The course of treatment and early post-operative outcomes of hip fracture patients, aged\u2009\u2265\u200970 years, using either warfarin, direct oral anticoagulants (DOACs), or adenosine diphosphate. (ADP) inhibitors were compared to age- and sex-matched controls not using such drugs, operated during the same observation period at the same hospital. All data were retrospectively collected from electronic medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      306 patients (53% of all operations; mean age 87 years, 63% females) were included. Patients using DOACs or ADP inhibitors had their operation later than controls and warfarin users (2 and 2.5 days, respectively, compared to 1 day after admission;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Antithrombotic use was also associated with later mobilization (cases 2nd vs. controls 1st post-operative day;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004) and greater use of red blood cell (RBC) transfusions (14% of warfarin, 26% of DOAC, and 10% of ADP inhibitor users received\u2009\u2265\u20092 units of RBCs, compared to 5% of controls;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). After adjustment for comorbidities, cognition, mobility, and disability, antithrombotic use was associated with RBC transfusions and use of DOACs with delayed surgery and RBC transfusions. There were no differences in 30-day mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Preoperative use of antithrombotic drugs may delay mobilization and increase the need for RBC transfusions after hip fracture surgery. Delayed surgery and mobilization may lead to worse rehabilitation outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-026-01581-0","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:26:26Z","timestamp":1787660786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative antithrombotic use is associated with delayed mobilization and plural blood transfusions following hip fracture surgery: a case\u2013control study"],"prefix":"10.1007","author":[{"given":"Henrik","family":"Nupponen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Pajulammi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anssi","family":"Korppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8218-7432","authenticated-orcid":false,"given":"Esa","family":"J\u00e4msen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"1","key":"1581_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12877-016-0332-0","volume":"16","author":"SM Dyer","year":"2016","unstructured":"Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID et al (2016) A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr 16(1):58","journal-title":"BMC Geriatr"},{"key":"1581_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.archger.2015.05.007","volume":"61","author":"HM Pajulammi","year":"2015","unstructured":"Pajulammi HM, Pihlajam\u00e4ki HK, Luukkaala TH, Nuotio MS (2015) Pre- and perioperative predictors of changes in mobility and living arrangements after hip fracture\u2014A population-based study. Arch Gerontol Geriatr 61:182\u2013189","journal-title":"Arch Gerontol Geriatr"},{"key":"1581_CR3","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620x.101b9.bjj-2019-0295.r1","author":"S Leer-Salvesen","year":"2019","unstructured":"Leer-Salvesen S, Enges\u00e6ter LB, Dybvik E, Furnes O, Kristensen TB, Gjertsen JE (2019) Does time from fracture to surgery affect mortality and intraoperative medical complications for hip fracture patients? An observational study of 73 557 patients reported to the Norwegian hip fracture register. Bone Joint J. https:\/\/doi.org\/10.1302\/0301-620x.101b9.bjj-2019-0295.r1","journal-title":"Bone Joint J"},{"key":"1581_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-32098-7","volume":"8","author":"T Klestil","year":"2018","unstructured":"Klestil T, R\u00f6der C, Stotter C, Winkler B, Nehrer S, Lutz M et al (2018) Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta-analysis. Sci Rep 8:1\u201315","journal-title":"Sci Rep"},{"key":"1581_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-018-2093-8","volume":"19","author":"B Su","year":"2018","unstructured":"Su B, Newson R, Soljak H, Soljak M (2018) Associations between post-operative rehabilitation of hip fracture and outcomes: national database analysis. BMC Musculoskelet Disord 19:1\u20139","journal-title":"BMC Musculoskelet Disord"},{"key":"1581_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/msc.1863","author":"N Agarwal","year":"2024","unstructured":"Agarwal N, Feng T, Maclullich A, Duckworth A, Clement N (2024) Early mobilisation after hip fracture surgery is associated with improved patient outcomes: a systematic review and meta\u2010analysis. Musculoskelet Care. https:\/\/doi.org\/10.1002\/msc.1863","journal-title":"Musculoskelet Care"},{"key":"1581_CR7","doi-asserted-by":"publisher","first-page":"215145931876415","DOI":"10.1177\/2151459318764150","volume":"9","author":"R Taranu","year":"2018","unstructured":"Taranu R, Redclift C, Williams P, Diament M, Tate A, Maddox J et al (2018) Use of Anticoagulants Remains a Significant Threat to Timely Hip Fracture Surgery. Geriatr Orthop Surg Rehabil 9:215145931876415","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"1581_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13018-020-01624-7","volume":"15","author":"Z Yang","year":"2020","unstructured":"Yang Z, Ni J, Long Z, Kuang L, Gao Y, Tao S (2020) Is hip fracture surgery safe for patients on antiplatelet drugs and is it necessary to delay surgery? A systematic review and meta-analysis. J Orthop Surg Res 15:105","journal-title":"J Orthop Surg Res"},{"key":"1581_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11999-016-5056-0","volume":"475","author":"JE Lawrence","year":"2017","unstructured":"Lawrence JE, Fountain DM, Cundall-Curry DJ, Carrothers AD (2017) Do patients taking warfarin experience delays to theatre, longer hospital stay, and poorer survival after hip fracture? Clin Orthop Relat Res 475:273\u2013279","journal-title":"Clin Orthop Relat Res"},{"key":"1581_CR10","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1097\/BOT.0000000000001329","volume":"33","author":"M Bruckbauer","year":"2019","unstructured":"Bruckbauer M, Prexl O, Voelckel W, Ziegler B, Grottke O, Maegele M et al (2019) Impact of direct oral anticoagulants in patients with hip fractures. J Orthop Trauma 33:E8-13","journal-title":"J Orthop Trauma"},{"key":"1581_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.thromres.2019.11.005","volume":"184","author":"T Cafaro","year":"2019","unstructured":"Cafaro T, Simard C, Tagalakis V, Koolian M (2019) Delayed time to emergency hip surgery in patients taking oral anticoagulants. Thromb Res 184:110\u2013114","journal-title":"Thromb Res"},{"key":"1581_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s41999-020-00319-w","volume":"11","author":"S Leer-Salvesen","year":"2020","unstructured":"Leer-Salvesen S, Dybvik E, Ranhoff AH, Huseb\u00f8 BL, Dahl OE, Enges\u00e6ter LB et al (2020) Do direct oral anticoagulants (DOACs) cause delayed surgery, longer length of hospital stay, and poorer outcome for hip fracture patients? Eur Geriatr Med 11:563\u2013569","journal-title":"Eur Geriatr Med"},{"key":"1581_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s41999-020-00293-3","volume":"11","author":"S L\u00f3pez","year":"2020","unstructured":"L\u00f3pez S, da Casa C, Pablos-Hern\u00e1ndez C, Pescador D, D\u00edaz-\u00c1lvarez A, Asensio N et al (2020) The impact of antithrombotic therapy on surgical delay and 2-year mortality in older patients with hip fracture: a prospective observational study. Eur Geriatr Med 11:555\u2013561","journal-title":"Eur Geriatr Med"},{"issue":"2","key":"1581_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1302\/0301-620X.103B2.BJJ-2020-0583.R2","volume":"103-B","author":"D You","year":"2021","unstructured":"You D, Xu Y, Ponich B, Ronksley P, Skeith L, Korley R et al (2021) Effect of oral anticoagulant use on surgical delay and mortality in hip fracture. Bone Joint J 103-B(2):222\u2013233","journal-title":"Bone Joint J"},{"key":"1581_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2025.112217","volume":"56","author":"JB Baldino","year":"2025","unstructured":"Baldino JB, Bellas NJ, Solomito MJ, Kumar M, Davis SL (2025) Direct oral anticoagulants (DOACs) increase time to operating room without increasing postoperative hematologic complications in patients with fragility fractures of the proximal femur. Injury 56:112217","journal-title":"Injury"},{"key":"1581_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00198-018-4786-0","volume":"30","author":"C Daugaard","year":"2019","unstructured":"Daugaard C, Pedersen AB, Kristensen NR, Johnsen SP (2019) Preoperative antithrombotic therapy and risk of blood transfusion and mortality following hip fracture surgery: a Danish nationwide cohort study. Osteoporosis Int 30:583\u2013591","journal-title":"Osteoporosis Int"},{"key":"1581_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/BOT.0000000000002753","volume":"38","author":"DT Brameier","year":"2024","unstructured":"Brameier DT, Tischler EH, Ottesen TD, McTague MF, Appleton PT, Harris MB et al (2024) Use of direct oral anticoagulants among patients with hip fracture is not an indication to delay surgical intervention. J Orthop Trauma 38:148\u2013154","journal-title":"J Orthop Trauma"},{"key":"1581_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.archger.2015.01.017","volume":"60","author":"B Buecking","year":"2015","unstructured":"Buecking B, Bohl K, Eschbach D, Bliemel C, Aigner R, Balzer-Geldsetzer M et al (2015) Factors influencing the progress of mobilization in hip fracture patients during the early postsurgical period?-A prospective observational study. Arch Gerontol Geriatr 60:457\u2013463","journal-title":"Arch Gerontol Geriatr"},{"key":"1581_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1519\/JPT.0000000000000284","volume":"44","author":"CM Said","year":"2021","unstructured":"Said CM, Delahunt M, Ciavarella V, al Maliki D, Boys A-M, Vogrin S et al (2021) Factors impacting early mobilization following hip fracture: an observational study. J Geriatr Phys Ther 44:88\u201393","journal-title":"J Geriatr Phys Ther"},{"key":"1581_CR20","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1055\/s-0038-1675400","volume":"118","author":"ED Borre","year":"2018","unstructured":"Borre ED, Goode A, Raitz G, Shah B, Lowenstern A, Chatterjee R et al (2018) Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review. Thromb Haemost 118:2171\u20132187","journal-title":"Thromb Haemost"},{"key":"1581_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.thromres.2018.04.022","volume":"166","author":"T Frenkel Rutenberg","year":"2018","unstructured":"Frenkel Rutenberg T, Velkes S, Vitenberg M, Leader A, Halavy Y, Raanani P et al (2018) Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants. Thromb Res 166:106\u2013112","journal-title":"Thromb Res"},{"key":"1581_CR22","doi-asserted-by":"publisher","first-page":"E170","DOI":"10.1503\/cjs.010021","volume":"66","author":"D You","year":"2023","unstructured":"You D, Xu Y, Krzyzaniak H, Korley R, Carrier M, Schneider P (2023) Safety of expedited-surgery protocols in anticoagulant-treated patients with hip fracture: a systematic review and meta-analysis. Can J Surg 66:E170\u2013E180","journal-title":"Can J Surg"},{"key":"1581_CR23","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s00198-025-07659-y","volume":"36","author":"S Wijekulasuriya","year":"2025","unstructured":"Wijekulasuriya S, Seymour H, Tarrant S, Balogh ZJ, Navarre P, Hallen J et al (2025) The impact of direct oral anticoagulants on hip fracture care in Australia and New Zealand: a prospective patient sprint audit. Osteoporosis Int 36:2137\u20132147","journal-title":"Osteoporosis Int"},{"key":"1581_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2024.111451","volume":"55","author":"MM Farhan-Alanie","year":"2024","unstructured":"Farhan-Alanie MM, Chinweze R, Walker R, Eardley WGP (2024) The impact of anticoagulant medications on fragility femur fracture care: the hip and femoral fracture anticoagulation surgical timing evaluation (HASTE) study. Injury 55:111451","journal-title":"Injury"},{"key":"1581_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1160\/TH16-04-0266","volume":"116","author":"C Chai-Adisaksopha","year":"2016","unstructured":"Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A et al (2016) Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal: a systematic review and meta-analysis. Thromb Haemost 116:879\u2013890","journal-title":"Thromb Haemost"},{"key":"1581_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcot.2020.08.005","volume":"12","author":"R Shah","year":"2021","unstructured":"Shah R, Sheikh N, Mangwani J, Morgan N, Khairandish H (2021) Direct oral anticoagulants (DOACs) and neck of femur fractures: standardising the perioperative management and time to surgery. J Clin Orthop Trauma 12:138\u2013147","journal-title":"J Clin Orthop Trauma"},{"key":"1581_CR27","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa2113514","volume":"385","author":"MD Neuman","year":"2021","unstructured":"Neuman MD, Feng R, Carson JL, Gaskins LJ, Dillane D, Sessler DI et al (2021) Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med 385:2025\u20132035","journal-title":"N Engl J Med"},{"key":"1581_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00402-020-03701-2","volume":"142","author":"ZB Cheung","year":"2021","unstructured":"Cheung ZB, Xiao R, Forsh DA (2021) Time to surgery and complications in hip fracture patients on novel oral anticoagulants: a systematic review. Arch Orthop Trauma Surg 142:633\u2013640","journal-title":"Arch Orthop Trauma Surg"},{"key":"1581_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/1120700019897878","volume":"31","author":"A Arshi","year":"2020","unstructured":"Arshi A, Lai WC, Iglesias BC, McPherson EJ, Zeegen EN, Stavrakis AI et al (2020) Blood transfusion rates and predictors following geriatric hip fracture surgery. Hip Int 31:272\u2013279","journal-title":"Hip Int"},{"key":"1581_CR30","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.arr.2013.07.003","volume":"12","author":"BT Wall","year":"2013","unstructured":"Wall BT, Dirks ML, van Loon LJC (2013) Skeletal muscle atrophy during short-term disuse: Implications for age-related sarcopenia. Ageing Res Rev 12:898\u2013906","journal-title":"Ageing Res Rev"},{"key":"1581_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12877-018-0755-x","volume":"18","author":"OM Steihaug","year":"2018","unstructured":"Steihaug OM, Gjesdal CG, Bogen B, Kristoffersen MH, Lien G, Hufthammer KO et al (2018) Does sarcopenia predict change in mobility after hip fracture? A multicenter observational study with one-year follow-up. BMC Geriatr 18:65","journal-title":"BMC Geriatr"},{"key":"1581_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s41999-020-00317-y","volume":"11","author":"H Ferris","year":"2020","unstructured":"Ferris H, Brent L, Coughlan T (2020) Early mobilisation reduces the risk of in-hospital mortality following hip fracture. Eur Geriatr Med 11:527\u2013533","journal-title":"Eur Geriatr Med"},{"key":"1581_CR33","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1302\/0301-620X.103B7.BJJ-2020-2349.R1","volume":"103","author":"A Goubar","year":"2021","unstructured":"Goubar A, Martin FC, Potter C, Jones GD, Sackley C, Ayis S et al (2021) The 30- day survival and recovery after hip fracture by timing of mobilization and dementia. Bone Joint J 103:1317\u20131324","journal-title":"Bone Joint J"},{"key":"1581_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/anae.15291","volume":"76","author":"R Griffiths","year":"2021","unstructured":"Griffiths R, Babu S, Dixon P, Freeman N, Hurford D, Kelleher E et al (2021) Guideline for the management of hip fractures 2020: guideline by the association of anaesthetists. Anaesthesia 76:225\u2013237","journal-title":"Anaesthesia"},{"key":"1581_CR35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/anae.16226","volume":"79","author":"RJ Mitchell","year":"2024","unstructured":"Mitchell RJ, Wijekulasuriya S, Mayor A, Borges FK, Tonelli AC, Ahn J et al (2024) Principles for management of hip fracture for older adults taking direct oral anticoagulants: an international consensus statement. Anaesthesia 79:627\u2013637","journal-title":"Anaesthesia"},{"key":"1581_CR36","unstructured":"Kearns R, Jenkins P, Bagot C. Clinical guideline. Anticoagulation management in patients admitted to orthopaedics with hip fractures. NHS Scotland. Available online: https:\/\/www.rightdecisions.scot.nhs.uk\/ggc-clinical-guidelines\/anaesthesia\/patient-care\/external-drug-management\/anticoagulation-management-in-patients-admitted-to-orthopaedics-with-hip-fractures-424\/ Accessed Jan 15 2026"},{"key":"1581_CR37","doi-asserted-by":"publisher","first-page":"afad216","DOI":"10.1093\/ageing\/afad216","volume":"52","author":"A Pilotto","year":"2023","unstructured":"Pilotto A, Veronese N, Polidori MC, Strandberg T, Topinkova E, Cruz-Jentoft AJ et al (2023) Frailty and anticoagulants in older subjects with atrial fibrillation: the EUROSAF study. Age Ageing 52:afad216","journal-title":"Age Ageing"},{"key":"1581_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108081","volume":"33","author":"BA Williams","year":"2024","unstructured":"Williams BA, Blankenship JC, Voyce S, Chang AR (2024) Trends over time in oral anticoagulation and stroke rates in atrial fibrillation: a community-based study. J Stroke Cerebrovasc Dis 33:108081","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-026-01581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-026-01581-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-026-01581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:26:28Z","timestamp":1787660788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-026-01581-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":38,"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1007\/s41999-026-01581-0","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HN and AK have no competing interests. HP and EJ have received speaker honoraria from pharmaceutical companies (HP: Bristol Myers Squibb\u2013Pfizer Alliance; EJ: Chiesi Pharma AB, H. Lundbeck A\/S, Novartis AG). EJ is a member of the advisory panel of the Finnish database for potentially inappropriate medicines (Meds75\u2009+).","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval from ethics committee was not required for this registry-based study. The use of patient records was authorized by the hospital according to local guidelines (R18568S).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was not required for this type of study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}